A group of experts discusses the use of continuous glucose monitoring (CGM) technology in diabetes and its transformative potential in managing the disease.
Today, we are bringing you a conversation on the use of continuous glucose monitoring (CGM) technology and its transformative potential in diabetes care.
Davida Kruger, NP, a certified nurse practitioner at Henry Ford in the Division of Endocrinology, spoke with:
The topics of conversation for today’s podcast include how CGM addresses therapeutic inertia, enhances glycemic control, and drives improvements in patient outcomes and health care efficiency, as well as the barriers to adoption, strategies for expanding access, and the cost-effectiveness of CGM implementation.
While CGM use started with patients with type 1 diabetes, it has transitioned to use in type 2 diabetes, Neeland explained. CGM allows for “more real-time, faster therapeutic interventions,” Wigginton added.
“I think we all know that the CGM in the right patient population with the right physician and the right care team managing that data can absolutely improve clinical inertia to earlier intervention [and] better patient outcomes,” he said. “I think that's a well-known fact that that can happen.”
CGM can provide several metrics beyond just actual glucose, and since the technology provides a 10- to 14-day snapshot of data, it provides average glucose, time in range, the Glucose Management Indicator, and glucose variability. These metrics are now also playing a role in Healthcare Effectiveness Data and Information Set measures and quality targets for accountable care organizations, Cohen noted.
However, there are varying coverage policies for CGM that impact patient access and outcomes.
“Health plans need to standardize more their coverage decisions, and that has to be done based on evidence-based medicine,” Murillo said. “There is this perception out there that health plans make unilateral decisions based on their own convenience. The reality is all those coverage decisions should be based on evidence.”
Listen above or through one of these podcast services:
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Supplemental Dental, Vision Benefits May Not Justify MA Payments for VA-Covered Veterans
May 22nd 2025Veterans primarily receiving care through the Department of Veterans Affairs (VA) similarly used dental and vision services under Medicare Advantage (MA) and traditional Medicare, challenging the justification for full MA capitated payments based on supplemental benefits.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Health Policy in Flux: Trump Administration Updates
May 20th 2025HHS announces it is taking steps to implement President Trump’s Executive Order on prescription drug pricing. Keep up with the latest moves made in health policy under President Donald Trump's second administration. This timeline will be updated as orders and policy progress.
Read More
Is the US Headed for an Infectious Disease Pandemic?
May 20th 2025In an era that FDA Commissioner Marty Makary, MD, MPH, calls an "epidemic of distrust" toward health institutions, previously contained disease rates are rapidly rising, and vaccination rates are proceeding in the opposite direction.
Read More